50位港大學者獲嘉許為「2023年度最廣獲徵引研究人員」 排名全球13位
HKU Achieves 13th Global Position with Record 50 Academics on Clarivate's Highly
⾹港⼤學理學院化學系李學臣教授的研究團隊歷時⼗年研發的抗⽣素新藥 ——咔喏霉素 (Kynomycin),剛獲得國家藥品監督管理局核准簽發《藥物臨床試驗批准通知書》,同意開展作臨床試驗。咔喏霉素是具有全新化學結構的環脂肽類 1 類化學新藥,主要針對細菌導致的複雜性⽪膚及軟組 織感染。
New Antibiotic Drug Developed by HKU Chemistry Research Team Approved for Clinical Trials in Humans
港⼤團隊開發雙重特洛伊⽊⾺⾦屬-鐵霉素複合物 為對抗细菌耐藥性提供新思路
HKU Scientists Pioneer Dual Trojan Horse Approach to Combat Superbugs
⾹港⼤學(港⼤)化學系裴達偉教授、江蘇⼤學杜莉莉教授(港⼤博⼠校友)、⾹港城市⼤學(城⼤)葉汝全教授及中國科學院上海有機化學研究所⽥佳教授領導的研究團隊,開發了⼀種環保光催c化系統,利⽤光能進⾏⾼效率的光催化過程。
Professor Phillips and his team developed a stable, recyclable and eco-friendly photocatalytic system that harnesses light energy efficiently.
港⼤化學系研究團隊開發了⼀種名為 MicroSpine 的微⽶級仿脊椎結構,其靈活變形的特性能夠協助執⾏在微⽶級的複雜任務。
Our Chemists developed a method to create microscale superstructures using both soft and hard materials, which possess shape-transforming properties.
香港大學(港大)化學系郭正曉教授、清華大學化學工程系唐軍旺教授與倫敦大學學院研究人員共同開發了一種高活性和高選擇性的催化材料。
Chemists developed a highly active and selective catalytic material that can efficiently convert a potent greenhouse into an essential chemical.
港⼤⽣物科學學院陳英偉博⼠領導的研究團隊,近⽇揭⽰了⼀種名為 ANKLE1 的酶的獨有功能。ANKLE1 能通過切割這些染⾊質橋阻⽌遺傳物質的斷裂,從⽽避免免疫系統錯誤地攻擊⾃身的細胞。理解染⾊質橋在細胞分裂過程中被切割的機制,對發展能防治癌症和⾃身免疫等疾病 的醫療策略至關重要。
A research team has discovered the function of a unique enzyme called ANKLE1.
Colloid chemistry is a complex and fascinating field that deals with the behavior of particles that are smaller than a micrometer in size.
古藥新⽤:⼆千年歷史抗菌藥硝酸銀 與「最後防線抗⽣素」粘菌素組合 可對抗耐藥性超級細菌e-sensitise the last-line Antimicrobial Colistin against superbugs
Re-sensitise the last-line Antimicrobial Colistin against superbugs
Young researchers at the University of Hong Kong have achieved excellent results in the inaugural round of the 2021 Excellent Young Scientists Fund...
國家自然科學基金「優秀青年科學家基金項目」,今年起首次開放給香港及澳門八間大學的年青學者申請。剛公佈的結果,優秀青年科學家基金項目(港澳)25個名額中,香港大學有七個項目獲選,是所有院校中最多
Individual Dr ANG Sze Wei, School of Humanities (Comparative Literature) Professor Pauline CHIU, Department of Chemistry Dr Brian CHUNG Hon...
1 / 2